Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
207,440,936
-
Total 13F shares
-
15,788,626
-
Share change
-
-625,144
-
Total reported value
-
$266,644,000
-
Put/Call ratio
-
61%
-
Price per share
-
$16.91
-
Number of holders
-
104
-
Value change
-
-$13,544,152
-
Number of buys
-
50
-
Number of sells
-
46
Institutional Holders of Esperion Therapeutics, Inc. - Common Stock, par value $0.001 per share (ESPR) as of Q1 2016
As of 31 Mar 2016,
Esperion Therapeutics, Inc. - Common Stock, par value $0.001 per share (ESPR) was held by
104 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
15,788,626 shares.
The largest 10 holders included
Aisling Capital LLC, Pentwater Capital Management LP, FMR LLC, COLUMBUS CIRCLE INVESTORS, BB BIOTECH AG, DISCOVERY CAPITAL MANAGEMENT, LLC / CT, WASATCH ADVISORS INC, VANGUARD GROUP INC, Sarissa Capital Management LP, and Voya Investment Management LLC.
This page lists
104
institutional shareholders reporting positions in this security
for the Q1 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.